AbCellera (ABCL) reported Q4 EPS of ($0.10), $0.11 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $21.5 million versus the consensus estimate of $50.8 million.
AbCellera (ABCL) reported Q4 EPS of ($0.10), $0.11 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $21.5 million versus the consensus estimate of $50.8 million.